Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma
We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case is the earliest to demonstrate activity of an oral multi-targeted kinase inhibitor in Ewing sarcoma. This...
Main Authors: | Steven Attia, Scott H. Okuno, Steven I. Robinson, Nicolas P. Webber, Daniel J. Indelicato, Robin L. Jones, Sanjay P. Bagaria, Courtney Sherman, Kevin R. Kozak, Cherise M. Cortese, Thomas MacFarland, Jonathan C. Trent, Robert G. Maki |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-05-01
|
Series: | Rare Tumors |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/rt/article/view/5992 |
Similar Items
-
Anomalous chin lesion: The many presentations of extraosseous Ewing's sarcoma
by: Tripthi P Shetty, et al.
Published: (2022-01-01) -
Unusual Manifestation of Extraosseous Ewing Sarcoma: Report of 3 Cases
by: Ioannidou M., et al.
Published: (2022-12-01) -
Extraosseous Ewing Sarcoma in a Pelvic Region: A Case Report
by: Sushma Gurung, et al.
Published: (2022-07-01) -
Extraosseous Ewing’s tumor of lateral abdominal wall
by: Nikhil Gupta, et al.
Published: (2011-11-01) -
Extraosseous Ewing Sarcoma in Children: A Systematic Review and Meta-Analysis of Clinicodemographic Characteristics
by: Maher Ghandour, et al.
Published: (2022-11-01)